<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Increased activity of the hypothalamic-pituitary-adrenal (<z:chebi fb="5" ids="53393">HPA</z:chebi>) axis may underlie the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, but whether circulating <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels predict cardiovascular end points is less clear </plain></SENT>
<SENT sid="1" pm="."><plain>People with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are at increased <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> risk and thus are suitable to study associations of plasma <z:chebi fb="1" ids="17650">cortisol</z:chebi> with cardiovascular risk </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: We aimed to assess whether altered <z:chebi fb="5" ids="53393">HPA</z:chebi> axis activity was associated with features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> in people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN AND SETTING: We conducted a cross-sectional cohort study in the general community, including 919 men and women aged 67.9 (4.2) yr with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (the Edinburgh Type 2 <z:mp ids='MP_0002055'>Diabetes</z:mp> Study) </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTION: We measured fasting morning plasma <z:chebi fb="1" ids="17650">cortisol</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASUREMENT: Associations between <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels, features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, and <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> were determined </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Elevated plasma <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels were associated with raised fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and total cholesterol levels (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>These findings remained significant after adjustment for potential confounding factors (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Elevated <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels were associated with prevalent <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (&gt;800 vs. &lt;600 nmol/liter; odds ratio, 1.58; P = 0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>This association remained significant after adjustment for duration and control of <z:mp ids='MP_0002055'>diabetes</z:mp> and other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> (P = 0.03) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The previously described associations between <z:chebi fb="5" ids="53393">HPA</z:chebi> axis activation and features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> are present among people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Elevated plasma <z:chebi fb="1" ids="17650">cortisol</z:chebi> is also associated with a greater prevalence of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, independent of conventional risk factors </plain></SENT>
<SENT sid="12" pm="."><plain>Understanding the role of <z:chebi fb="1" ids="17650">cortisol</z:chebi> in the pathogenesis of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> merits further exploration </plain></SENT>
</text></document>